苦参素降低大鼠肾脏缺血-再灌注损伤

基础医学与临床 ›› 2012, Vol. 32 ›› Issue (8): 943-947.

苦参素降低大鼠肾脏缺血-再灌注损伤

贾昌盛¹,孙建军²,李美德³,黎金浓³,陈瑞琦³,曾明¹,廖联明⁴

1. 安徽医科大学北京军区总医院临床学院
2. 南京军区福州总医院四七六临床部
3. 福建中医药大学中西医结合研究院
4. 福建中医药大学

收稿日期:2012-04-25 修回日期:2012-06-21 出版日期:2012-08-05 发布日期:2012-07-17
通讯作者: 曾明 E-mail:cute_z@126.com

Oxymatrine attenuates ischemia/reperfusion injury in rat kidneys

Received:2012-04-25 Revised:2012-06-21 Online:2012-08-05 Published:2012-07-17

摘要/Abstract

摘要： 目的观察苦参素的抗大鼠肾缺血再灌注损伤的作用并从抗氧化方面探讨其机制。方法用双肾肾蒂夹闭45min建立IRI模型，将SD大鼠随机分为假手术组，（sham）；缺血再灌注组，（I/R）；苦参素治疗组，（oxymatrine+I/R）。苦参素治疗组又分为高、中和低三个剂量组，在缺血再灌注前，连续七天经腹腔注射。用自动生化仪测定血清肌酐（Scr）和尿素氮（BUN）水平，观察苦参素对肾缺血再灌注的保护作用及确定最优剂量；以最优剂量干预用分光分析法测定肾组织丙二醛(MDA)、谷胱甘肽过氧化物酶(GSH-Px)、过氧化氢酶(CAT)、超氧化物歧化酶(SOD)水平。结果不同剂量组均能明显减轻肾脏IRI的病理形态学改变，改善肾功能。与I/R组相比，再灌注72h后，MDA水平，血清肌酐（Scr）和尿素氮（BUN）水平明显降低(P<0.05)；苦参素治疗组的CAT、T-SOD、GSH-Px活性改善明显(P﹤0.05)。苦参素无体外抗氧化作用。结论苦参素对大鼠肾缺血再灌注损伤具有保护作用，作用机制可能与调控机体的抗氧化系统有关。

关键词: 苦参素, 肾脏, 缺血再灌注损伤

Abstract: Objective Renal ischemia followed by reperfusion leads to acute renal failure, which is a complex pathophysiologic process involving hypoxia and free radical (FR) damage. We investigated the effect of oxymatrine on kidney ischemia/reperfusion (I/R) injury and the antioxidant effects of oxymatrine in rats. Methods SD rats were randomly divided into 5 groups (I/R group, sham operation group and oxymatrine treatment groups). Rats in the I/R group were subjected to bilateral renal ischemia for 45min and followed by reperfusion. Rats in the oxymatrine treatment groups received oxymatrine intraperitoneally (i.p.) at 3 different doses before I/R for 7 days. In some experiments, rats were killed and kidney function, tissue catalase (CAT), malondialdehyde (MDA) levels, superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities were determined. Results Oxymatrine significantly prevented I/R-induced kidney injury as indicated by decreased serum creatinine (Scr) and blood urea nitrogen (BUN) levels compared to I/R group (p <0.05). Reduction of tissue CAT, SOD and GSH-Px activities after I/R were significantly improved by oxymatrine (p <0.05). Treatment with oxymatrine also resulted in significant reduction in tissue MDA that was increased by renal I/R injury (p <0.05). Conclusion Based on our results, it could therefore be concluded that oxymatrine protects the kidneys against I/R injury at least partly via its antioxidant effects.

Key words: Oxymatrine, Kidney, Ischemia-Reperfusion Injury

中图分类号:

R282.71

贾昌盛孙建军李美德黎金浓陈瑞琦曾明廖联明. 苦参素降低大鼠肾脏缺血-再灌注损伤[J]. 基础医学与临床, 2012, 32(8): 943-947.

[1]	李莎莎刘其锋何敖林. 表观遗传调控异常在慢性肾脏病Klotho减少中的作用[J]. 基础医学与临床, 2019, 39(9): 1366-1370.
[2]	陶鹏宇张悦. SIRT1在糖尿病肾病进展中的作用[J]. 基础医学与临床, 2019, 39(3): 439-443.
[3]	刘莎韩雪郭维康刁宗礼刘文虎. Apelin改善慢性肾脏病大鼠血管钙化[J]. 基础医学与临床, 2019, 39(10): 1388-1392.
[4]	肖枫林王圣元李明旭. FGF9和CHIR99021诱导胚胎干细胞形成肾脏样结构[J]. 基础医学与临床, 2018, 38(6): 759-763.
[5]	周路平陈娇徐勇黄炜龙洋丁静雅秦露丹. RIPK2介导自噬对高糖诱导的小鼠肾系膜细胞ROS、caspase-1及IL-1β表达的激活作用[J]. 基础医学与临床, 2018, 38(10): 1389-1396.
[6]	敖当唐兰芬周璇. 利拉鲁肽减轻新生大鼠脑缺血再灌注损伤[J]. 基础医学与临床, 2017, 37(2): 245-248.
[7]	吴燕升高建东. 细胞焦亡在肾脏炎性反应中的作用研究进展[J]. 基础医学与临床, 2017, 37(10): 1470-1473.
[8]	于立明段维勋赵国龙张秋芳王晓武金振晓俞世强. 小檗碱减轻大鼠心肌缺血再灌注损伤[J]. 基础医学与临床, 2016, 36(4): 433-438.
[9]	李丽昕付国俊孟晨阳. 饱和氢盐水对大鼠心肌缺血再灌注损伤致炎性细胞因子的影响[J]. 基础医学与临床, 2013, 33(4): 490-491.
[10]	吴雪梅王琛谢红乔世刚覃琴刘霞. NF-кB参与七氟烷预处理延迟性大鼠心肌缺血再灌注损伤[J]. 基础医学与临床, 2013, 33(1): 39-43.
[11]	张永军王家宁唐俊明黄永章杨建业郭凌郧郑飞. PEP-1-CAT融合蛋白预处理减轻在体大鼠心肌缺血再灌注损伤 [J]. 基础医学与临床, 2011, 31(3): 316-317.
[12]	覃琴谢红王琛刘霞朱江吴雪梅. NF-кB参与七氟烷预处理减轻大鼠心肌缺血再灌注损伤 [J]. 基础医学与临床, 2011, 31(3): 247-251.
[13]	徐虹洪礼传黄艳秋陈素辉孙华. 针刺对脑缺血再灌注模型大鼠脑组织基质金属蛋白酶、细胞间黏附分子表达的影响[J]. 基础医学与临床, 2010, 30(7): 731-736.
[14]	张艳芳杨瑞王芳杨廷桐. 大鼠心肌缺血再灌注交界区p53和Caspase-3表达的变化[J]. 基础医学与临床, 2010, 30(5): 544-546.
[15]	许静张云芬张雅中裴玉梅房辉. 缺碘致甲状腺功能减退大鼠肾脏抗氧化能力降低[J]. 基础医学与临床, 2010, 30(4): 374-377.